Cannabidiol (CBD) is starting to gain momentum worldwide as time goes on and Charlotte’s Web Holdings is not hesitating to capitalize on the trend. The market leader in this famous cannabis compound recently announced that it has passed validation for its Novel Food applications by the Food Standards Agency (FSA) in the UK. This means that its original formula full-spectrum hemp extract product is now welcome in the European country.
There is no doubt that the company’s original formula has achieved a unique milestone after receiving this important news. Charlotte’s Web is currently the only US-based vertically integrated company with a full-spectrum hemp extract that was able to complete this important validation phase, advancing to the safety evaluation phase. The recent achievement uniquely positions the brand in the growing CBD market that the UK has been experiencing for a number of years.
The quality stages of Charlotte’s Web’s product are constantly monitored, from soil and seed to the final product. The company’s dedication and investment in vertical integration has led it to be highly recognized by leading authorities in both the EU and the UK. This is clearly reflected in the approval at this next stage of Novel Food’s application process.
As usual, Jacques Tortoroli, CEO of Charlotte’s Web, was keen to address the issue and began. He stated that the company is fully aware that product quality, safety and brand values are important factors for consumers looking for overall health in full-spectrum premium products.
Tortoroli added, “It’s critical to scaffold these emerging markets with the high bar set by our proprietary hemp genetics, scientific rigor, and innovation practices. International audiences are only now learning the difference between full-spectrum and isolate CBD products, which provides a great opportunity for education, product differentiation, and consumer adoption as they begin to understand the health advantages inherent in full-spectrum products.”